Protection after two doses of measles vaccine is independent of interval between doses

被引:18
作者
De Serres, G
Sciberras, J
Naus, M
Boulianne, N
Duval, B
Rochette, L
机构
[1] CHUL, Res Ctr, Publ Hlth Res Inst, Quebec City, PQ, Canada
[2] Univ Laval, Dept Social & Prevent Med, Toronto, ON, Canada
关键词
D O I
10.1086/314847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The protection provided by one or two doses of measles vaccine was compared, as was the effect of the timing of delivery of the doses on the protection provided. A total of 5542 measles cases occurred in Ontario, Canada, between January 1990 and December 1996. Three controls per case were matched for age and residence. Children who received a single dose at age 15 months and older were 5 times more likely to contract measles than were children who received two doses of vaccine after their first birthday Among children given two doses of vaccines, the risk of measles was 3 times greater in those who had their first vaccination at age 11 months compared with children who first received vaccine after age 1 year, but the protection was independent of the interval between doses. Delaying the second dose >6 months after the first does not increase protection.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 13 条
  • [1] BLACK FL, 1984, B WORLD HEALTH ORGAN, V62, P315
  • [2] Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months
    Gans, HA
    Arvin, AM
    Galinus, J
    Logan, L
    DeHovitz, R
    Maldonado, Y
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (06): : 527 - 532
  • [3] LINNEMANN CC, 1982, PEDIATRICS, V69, P332
  • [4] PERSISTENCE OF MEASLES ANTIBODY AFTER REVACCINATION
    MARKOWITZ, LE
    ALBRECHT, P
    ORENSTEIN, WA
    LETT, SM
    PUGLIESE, TJ
    FARRELL, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) : 205 - 208
  • [5] Markowitz LE, 1994, VACCINES, P229
  • [6] *NAT ADV COMM IMM, 1991, CAN DIS WKLY REP, V17, P35
  • [7] Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine
    Paunio, M
    Peltola, H
    Valle, M
    Davidkin, I
    Virtanen, M
    Heinonen, OP
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1999, 53 (03) : 173 - 178
  • [8] THE ELIMINATION OF INDIGENOUS MEASLES, MUMPS, AND RUBELLA FROM FINLAND BY A 12-YEAR, 2-DOSE VACCINATION PROGRAM
    PELTOLA, H
    HEINONEN, OP
    VALLE, M
    PAUNIO, M
    VIRTANEN, M
    KARANKO, V
    CANTELL, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (21) : 1397 - 1402
  • [9] STETLER HC, 1986, PEDIATRICS, V77, P471
  • [10] CELLULAR-IMMUNITY IN MEASLES-VACCINE FAILURE - DEMONSTRATION OF MEASLES ANTIGEN-SPECIFIC LYMPHOPROLIFERATIVE RESPONSES DESPITE LIMITED SERUM ANTIBODY-PRODUCTION AFTER REVACCINATION
    WARD, BJ
    BOULIANNE, N
    RATNAM, S
    GUIOT, MC
    COUILLARD, M
    DESERRES, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) : 1591 - 1595